Compared with tamoxifen, aromatase inhibitors were revealed to be more effective in reducing the rate of recurrence in ER+ breast cancer among premenopausal women receiving ovarian suppression.
Lindsay Fischer
Advertisement
Articles by Lindsay Fischer
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
FDA approves cefepime and zidebactam intravenous antibiotic to treat adults with cUTI
2
Individualized TRT demonstrates broad symptom improvements beyond sexual function
3
Nearly 18 million US women aged 45 to 64 overdue for cancer screening, study finds
4
Acetaminophen remains first-line medication for pain, fever in pregnancy, SMFM says
5